Epigenetics of Depression

Natural and inherited factors have a strong impact on major depressive illness. These elements include epigenetic genome modification, which involves a continuous alteration in quality articulation without a change in the genuine DNA grouping. Hereditary and natural factors can have an impact on the genome during the course of a person's life; yet, during childhood, an individual is largely defenceless. Certain epigenetic variables, like as methylation, may serve as indicators for the efficacy of antidepressant therapy. Antidepressants can now be used to help people relax and reduce global DNA methylation levels.

  • Istone deacetylases
  • Histone methyltransferases
  • Brain-derived neurotrophic factor
  • Hypothalamic-pituitary-adrenal axis
  • Glial cell line-derived neurotrophic factor

    Related Conference of Epigenetics of Depression

    May 23-24, 2024

    41th Global Psychiatry and Mental Health Conference

    Zurich, Switzerland
    May 27-28, 2024

    6th European Autism Congress

    Paris, France
    July 15-16, 2024

    6th International Congress on Mental Health

    Amsterdam, Netherlands
    September 09-10, 2024

    16th International Conference on Addiction & Psychiatry

    Paris, France
    September 09-10, 2024

    5th Annual Congress on Psychiatry

    London, UK
    September 09-10, 2024

    9th International Conference on Addiction Therapy

    Paris, France
    December 05-06, 2024

    4th World Conference on Addiction Psychiatry

    Prague,
    March 10-11, 2025

    5th Annual Congress on Mental Health

    Paris, France

    Epigenetics of Depression Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in